The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

AI outperformed clinicians and almost matched hs-TnT testing, but one expert questioned if this is where it’s needed most.

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.